Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
Anna Randi, Professor of Cardiovascular Medicine at Imperial College London, shared on LinkedIn:
”Delighted to share the latest episode of the VWF and angiogenesis story from my lab Vascular Section – NHLI, Imperial College London.
Finally, experimental evidence that Angiopoietin2 inhibition could benefit VWD patients with GI bleeding and angiodysplasia.
This was true teamwork: thank you to the excellent members of my team at Imperial, particularly Adela Constantinescu-Bercu and Koval Smith, PhD, and a fantastic network of collaborators (Marco Rasponi, Petrova Lab – Vascular and tumor biology, Suthesh Sivapalaratnam).
A special thanks to the VWD patients who generously donated their blood to advance research.
Thank you to the Medical Research Council, the British Heart Foundation, the Rosetrees trust and the NIHR (National Institute for Health and Care Research) Imperial BRC.
Thank you to Barbara Bianchi Bonomi for the recent generous award, highlighting the relevance of this research to patients with VWD.
A hugely satisfying project with real life impact.”
Read the full article here.
Article: Von Willebrand Factor Deficiency Impairs Angiogenesis via Angiopoietin-2: Relevance for Gut Angiodysplasia
Authors: Adela Constantinescu-Bercu, Koval E Smith, Shuo Yi Wong, Mattia Ballerini, Alessia Nastro, Benjamin G Wiggins, Daniela Pirri, Yucheng Li, Juun Anora Maria Evers, Olga Tsiamita, Matthew Dibble, Charis Pericleous, Koralia E Paschalaki, Graeme M Birdsey, Jeremiah Bernier-Latmani, Tatiana V Petrova, Mike A Laffan, Suthesh Sivapalaratnam, Marco Rasponi, Anna M. Randi
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 25, 2026, 03:502026 Applications Open for The International Outreach Initiative – ASH
-
Apr 25, 2026, 02:51Roche Extends Support to Expand Global Access to Hemophilia Care – WFH
-
Apr 25, 2026, 02:44WFH Congress 2026 Participation Overview – WFH
-
Apr 25, 2026, 02:33Sara Zalghout: Platelet Glycans as Diagnostic and Therapeutic Targets
-
Apr 25, 2026, 02:20Pierpaolo Di Micco: Proud to Be Published in JAMA for the Third Time in Four Years
-
Apr 25, 2026, 02:11Kathryn Golab: Coagulation QA Essentials for Reliable Lot to Lot Testing
-
Apr 24, 2026, 23:36Pedro Perez: Are We Measuring the Right Outcomes in VTE?
-
Apr 24, 2026, 20:41Christine Ngaruiya: Malvika Krishnamurthy Highlights Biomarker Gaps in Stroke Research at Stanford Research Symposium
-
Apr 24, 2026, 17:58Erwin Loh: Triple Combination Therapy Shows Major Benefit in Preventing Recurrent Stroke